What is the evidence for choline supplementation in steatosis?

Prepare for the ASPEN Certified Nutrition Support Clinician (CNSC) Exam. Study with structured quizzes and detailed insights to enhance your knowledge and readiness. Get set for success!

Multiple Choice

What is the evidence for choline supplementation in steatosis?

Explanation:
Choline acts as a lipotropic nutrient, essential for the proper export of triglycerides from the liver as VLDL. In parenteral nutrition, choline deficiency can contribute to hepatic steatosis, so supplementation is studied as a way to counteract PN-associated liver changes. The best-supported statement is that investigations have reported steatosis resolving after choline supplementation, but there is a need for more research to evaluate whether choline can prevent and treat PN‑associated liver disease more broadly. While this points to a potential benefit, the evidence isn’t yet definitive or universal, so conclusive preventive claims aren’t made.

Choline acts as a lipotropic nutrient, essential for the proper export of triglycerides from the liver as VLDL. In parenteral nutrition, choline deficiency can contribute to hepatic steatosis, so supplementation is studied as a way to counteract PN-associated liver changes. The best-supported statement is that investigations have reported steatosis resolving after choline supplementation, but there is a need for more research to evaluate whether choline can prevent and treat PN‑associated liver disease more broadly. While this points to a potential benefit, the evidence isn’t yet definitive or universal, so conclusive preventive claims aren’t made.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy